Home › Trial NCT07871435
GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) (JET-201)
- Trial IDNCT07871435
- StatusRecruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorGI Innovation, Inc.
- Enrollment107
- Start date2026-10-12
- ConditionsMetastatic Castration-resistant Prostate Cancer (mCRPC)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.